Michael A. Mussallem - 31 Dec 2021 Form 5 Insider Report for Edwards Lifesciences Corp (EW)

Role
Chairman & CEO, Director
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
28 Jan 2022, 18:09:26 UTC
Previous filing
20 Dec 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Gift $0 -108,730 -58% $0.000000 79,272 03 Aug 2021 Direct
transaction EW Common Stock Gift $0 +108,730 +3.4% $0.000000 3,294,017 03 Aug 2021 By Living Trust F1
holding EW Common Stock 371,718 31 Dec 2021 401(k) F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the amount owned following this transaction as of August 3, 2021. The total amount owned as of December 31, 2021, which is the Issuer's fiscal year end, is 3,344,017 shares.
F2 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 5 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.